Are you living with metastatic prostate cancer?
The team at Pinpoint Patient Recruiting is searching for people diagnosed with
metastatic castrate-resistant prostate cancer (mCRPC), as well as their caregivers, to participate in a 45-minute online activity about their experiences. The information gathered will be used to help communication and education materials about mCRPC.
Will you qualify?
If you or the person you care for meet the following criteria, you may be eligible to participate:
have experience with a second-generation AR antagonists (such as enzalutamide, darolutamide, abiraterone or apalutamide) as part of mCRPC treatment
If you qualify for and complete the 45-minute online activity, you will receive a check for $100 as a thank you for participating.
*Please note, you must be a current resident of the US and 18 or older to qualify for and participate in this study. All information shared with Pinpoint will remain confidential.
You will be asked to join our community and answer a few quick questions to help match you to opportunities you may qualify for. You can opt out at any time by emailing firstname.lastname@example.org.